Anton Zawrocki
Overview
Explore the profile of Anton Zawrocki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
224
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Czajkowski M, Falis M, Zawrocki A, Sternau M, Lubiewski A, Rytlewska M, et al.
Cancers (Basel)
. 2025 Jan;
16(24.
PMID: 39766039
: Kidney cancer accounts for approximately 2% of all diagnosed cancers and fatalities worldwide, and a notable increase in its incidence has been observed in recent years. Previous studies have...
2.
Sznurkowski J, Zawrocki A, Krawczynska N, Bienkowski M, Wasag B, Biernat W
Medicina (Kaunas)
. 2022 May;
58(5).
PMID: 35630004
: It has been demonstrated that Egfl7 promotes tumor cell escape from immunity by downregulating the activation of tumor blood vessels. : to analyze mRNA expression of within the tumor...
3.
Slawinska M, Kaminska-Winciorek G, Balicka U, Zawrocki A, Nowicki R, Sobjanek M, et al.
Cancers (Basel)
. 2022 Apr;
14(8).
PMID: 35454827
Little is known about the correlation between lesion- and patient-related variables and the dermoscopic features of blue nevi. The aim of the study was dermoscopic analysis of blue nevi in...
4.
Olszewska B, Zawrocki A, Glen J, Lakomy J, Karczewska J, Zablotna M, et al.
Postepy Dermatol Alergol
. 2022 Apr;
39(1):81-87.
PMID: 35369626
Introduction: Cutaneous T-cell lymphomas (CTCL) are malignant lymphoproliferative disorders accompanied by persistent pruritus. Pruritogenic role of interleukin-31 (IL-31) has been studied extensively and was proven in atopic dermatitis (AD), while...
5.
Jassem-Bobowicz J, Klasa-Mazurkiewicz D, Zawrocki A, Stefanska K, Domzalska-Popadiuk I, Kwiatkowski S, et al.
Children (Basel)
. 2021 Oct;
8(10).
PMID: 34682151
Objective: To develop a multifactorial model that allows the prediction of bronchopulmonary dysplasia (BPD) in preterm newborns. Materials And Methods: A single-center retrospective study of infants born below 32 +...
6.
Czarny J, Renke J, Zawrocki A, Nowicki R, Lange M
Int J Dermatol
. 2021 Apr;
60(10):1253-1257.
PMID: 33904158
Background: Mastocytosis is a heterogeneous group of myeloproliferative disorders characterized by accumulation of clonal mast cells in various tissues. The aim of this study was to determine the symptoms evolution...
7.
Czajkowski M, Zawrocki A, Czajkowska K, Klacz J, Sokolowska-Wojdylo M, Biernat W, et al.
Urology
. 2020 Nov;
148:274-279.
PMID: 33248142
Objective: To assess the accuracy of clinical diagnoses and the true incidence of lichen sclerosus (LS) in patients with phimosis. Materials And Methods: The 92 adult male patients who were...
8.
Olszewska B, Zawrocki A, Lakomy J, Karczewska J, Glen J, Zablotna M, et al.
Int J Dermatol
. 2020 Jul;
59(9):1106-1112.
PMID: 32643174
Background: Deregulation of signal transducer and activator of transcription (STAT) signaling is known to participate in the pathogenesis of cutaneous T-cell lymphomas (CTCLs). However, published results regarding STAT expression in...
9.
Czarny J, Zuk M, Zawrocki A, Plata-Nazar K, Biernat W, Niedoszytko M, et al.
Acta Derm Venereol
. 2020 May;
100(10):adv00149.
PMID: 32399575
is missing (Short communication).
10.
Duchnowska R, Sperinde J, Czartoryska-Arlukowicz B, Mysliwiec P, Winslow J, Radecka B, et al.
Oncotarget
. 2017 Dec;
8(61):104149-104159.
PMID: 29262628
Lapatinib is a HER1 and HER2 tyrosine kinase inhibitor (TKI) approved in second line treatment of advanced or metastatic breast cancer following progression on trastuzumab-containing therapy. Biomarkers for activity of...